Psychiatry · Birmingham, AL
NPI
1043260409
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 Corporate Drive, Suite 125
Birmingham, AL, 35242
Phone (205) 329-7992
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
286 services
Medicare patients, 2024
113
Average age 56
Drug cost, 2024
$203K
5,638 prescriptions
Company payments, 2025
$203
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Garry S Grayson was code 99213 (office e&m - established), 192 times for 91 patients. In total Garry S Grayson billed 286 services in 4 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 192 | 91 | $47.21 | $9,064 |
| 99214 Office E&M - Established | Office | 48 | 34 | $61.92 | $2,972 |
| 99215 Office E&M - Established | Office | 45 | 18 | $107.61 | $4,843 |
By year: 2022 $21K for 335 services; 2023 $20K for 323 services; 2024 $17K for 286 services.
Medicare prescription drug claims, 2024
In 2024, the drug Garry S Grayson prescribed most often to Medicare patients was Quetiapine Fumarate, with 610 prescriptions and refills. In total Garry S Grayson wrote 5,638 Medicare prescriptions that cost $203K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 610 | 638 | 49 | $15K |
| Clonazepam Generic | 453 | 467 | 45 | $6,677 |
| Lorazepam Generic | 442 | 458 | 46 | $7,349 |
| Fluoxetine Hcl Generic | 303 | 312 | 30 | $4,635 |
| Chlorpromazine Hcl Generic | 264 | 269 | 20 | $38K |
| Divalproex Sodium Generic | 262 | 268 | 27 | $7,892 |
| Olanzapine Generic | 259 | 280 | 27 | $6,787 |
| Risperidone Generic | 254 | 264 | 22 | $4,232 |
| Mirtazapine Generic | 242 | 290 | 30 | $3,931 |
| Alprazolam Generic | 233 | 256 | 30 | $1,911 |
| Trazodone Hcl Generic | 213 | 251 | 27 | $2,846 |
| Benztropine Mesylate Generic | 212 | 215 | 19 | $2,555 |
| Naltrexone Hcl Generic | 182 | 185 | 17 | $15K |
| Divalproex Sodium Er Divalproex Sodium | 165 | 180 | 17 | $7,134 |
| Haloperidol Generic | 114 | 116 | 11 | $3,352 |
Brand drugs: 65 claims; generic drugs: 5,573 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Garry S Grayson $203 ($203 in general payments such as food, travel and fees) from 7 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $56.49.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $56.49 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $37.8 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $35.56 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $22.88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $19.7 |
| Lundbeck LLC | 1 | $16.5 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $14.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.